Pretreatment pulmonary tumor necrosis is a promising prognostic imaging biomarker for first-line anti-PD-1/PD-L1 therapy in advanced lung squamous cell carcinoma: a multi-institutional, propensity score-matching cohort analysis.
Zhong Q, Zhang L, Wu L, Zhao J, Sun J, Fang Y, Zhou J, Chu Q, Shen Y, Yang Z, Chen L, Huang M, Lin X, Liu Z, Shen P, Wang Z, Wang X, Wang H, Han C, Liu A, Zhang H, Ye F, Gao W, Wu F, Song Z, Chen S, Zhou C, Huang D, Zhang Q, Zheng X, Zheng X, Miao Q, Jiang K, Zou Z, Xu Y, Wu S, Wang H, Hong Y, Lu T, Li C, Huang C, Chen C, Lin G.
Zhong Q, et al. Among authors: zhou j, zhou c.
Ther Adv Med Oncol. 2024 Aug 5;16:17588359241266188. doi: 10.1177/17588359241266188. eCollection 2024.
Ther Adv Med Oncol. 2024.
PMID: 39108839
Free PMC article.